The Sandcat (GR44278) clinical trial is assessing the safety and efficacy of an experimental treatment called Vamikibart (RO7200220) administered intravitreally for patients with Uveitic Macular Oedema.
ClinicalTrials.gov Identifier: NCT05642325
Principal Investigator: Assoc Prof. Mei-Ling Tay-Kearney
For further information about this study, you may visit Clinical Trial Registry: www.clinicaltrials.gov/study/NCT05642325 or email clinicalresearch@lei.org.au.
